Skip to main content

interleukin 36 receptor antagonist

The IL36RN gene provides instructions for making a protein called interleukin 36 receptor antagonist (IL-36Ra). This protein is primarily found in the skin where it helps regulate inflammation, part of the body's early immune response. Inflammation in the skin is stimulated when other proteins called IL-36 alpha (α), IL-36 beta (β), or IL-36 gamma (γ) attach to (bind) a specific receptor protein. This binding turns on (activates) signaling pathways that promote inflammation, namely the NF-κB and MAPK pathways. To control inflammatory reactions, the IL-36Ra protein binds to the receptor protein so that IL-36α, IL-36β, and IL-36γ cannot. In this way, the IL-36Ra protein blocks (antagonizes) the receptor's activity.

Video picks for Genes
Video library

Normal function

The IL36RN gene provides instructions for making a protein called interleukin 36 receptor antagonist (IL-36Ra). This protein is primarily found in the skin where it helps regulate inflammation, part of the body's early immune response. Inflammation in the skin is stimulated when other proteins called IL-36 alpha (α), IL-36 beta (β), or IL-36 gamma (γ) attach to (bind) a specific receptor protein. This binding turns on (activates) signaling pathways that promote inflammation, namely the NF-κB and MAPK pathways. To control inflammatory reactions, the IL-36Ra protein binds to the receptor protein so that IL-36α, IL-36β, and IL-36γ cannot. In this way, the IL-36Ra protein blocks (antagonizes) the receptor's activity.

Conditions referring to this gene or chromosome

Other names

FIL1

FIL1(DELTA)

FIL1D

IL-1 related protein 3

IL-1F5

IL-36Ra

IL1F5

IL1HY1

IL1L1

IL1RP3

IL36RA

interleukin 1 family, member 5 (delta)

interleukin-1 HY1

interleukin-1 receptor antagonist homolog 1

interleukin-1-like protein 1

interleukin-36 receptor antagonist protein

MGC29840

PSORP

PSORS14

Patient picks for Genes

Related patient information and medicines

Mouth cancer

Patient information leaflet

Mouth cancer

Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. Immun... It is also sometimes called biological therapy: Recombinant interleukin (rIL-2) is.

Dilated cardiomyopathy

Patient information leaflet

Dilated cardiomyopathy

Dilated cardiomyopathy is a condition where the heart muscle becomes stretched and thin. The heart becomes enlarged (dilates) and pumps blood less well. This is a combination of an angiotensin receptor blocker ( valsartan Valsartan - a... Currently, in the UK, national guidelines advise that this is used only for people who are taking an ACE.

Antacids

Patient information leaflet

Antacids

Before the discovery of other more modern medicines, an... They were also used to help heal ulcers in the stomach and duodenum. Medicines called proton pump inhibitors (PPIs) Proton pump inhibitors and H2-receptor antagonists (commonly called H2 blockers) H2 blockers are now more widely used for these conditions. They are much more effective than.

Diabetic kidney disease

Patient information leaflet

Diabetic kidney disease

Diabetic kidney disease is a complication that occurs in some people with diabetes. An angiotensin-II receptor antagonist (AIIRA) There are several types and brands of this type of medication. ...an angiotensin receptor blocker , irbesartan Irbesartan - an angiotensin receptor blocker , losartan Losartan - an angiotensin receptor blocker ,.

Can I take Bisoprolol and Trimbow together?

Patient information leaflet

Can I take Bisoprolol and Trimbow together?

Bisoprolol and Trimbow (which contains formoterol) work in opposite ways on the airways. Bisoprolol may cause the airways to narrow, making it harder to breathe and potentially triggering asthma or COPD symptoms. It also makes the formoterol in the Trimbow inhaler less effective at opening your airways. Why this happens Bisoprolol is a.

Mastocytosis and mast cell disorders

Patient information leaflet

Mastocytosis and mast cell disorders

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (such as interferon), bone marrow transplant or... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 May 2017 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.